
    
      The scope of this open label clinical trial is to evaluate and confirm the performance of
      Papix acne scar in the prevention and improvement of acne scars in subject suffering for mild
      to moderate acne. The product will be applied for 8 consecutive weeks, 2 times per day into
      the face.

      The dermatologist will perform 3 clinical follow up visits to assess the efficacy and safety
      of the product.
    
  